Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.

Whatever the consensus opinion may be, our team at StockStory cuts through the noise by conducting independent analysis to determine a company’s long-term prospects. That said, here are three stocks facing legitimate challenges and some alternatives worth exploring instead.

Vishay Intertechnology (VSH)

Consensus Price Target: $17.50 (-6.1% implied return)

Named after the founder's ancestral village in present-day Lithuania, Vishay Intertechnology (NYSE: VSH) manufactures simple chips and electronic components that are building blocks of virtually all types of electronic devices.

Why Do We Think VSH Will Underperform?

1. Sales tumbled by 5% annually over the last two years, showing market trends are working against its favor during this cycle
2. Competitive supply chain dynamics and steep production costs are reflected in its low gross margin of 20.3%
3. Long-term business health is up for debate as its cash burn has increased over the last five years

Vishay Intertechnology is trading at $18.64 per share, or 32.2x forward P/E. If you’re considering VSH for your portfolio, see our FREE research report to learn more.

Textron (TXT)

Consensus Price Target: $97.74 (-0.5% implied return)

Listed on the NYSE in 1947, Textron (NYSE: TXT) provides products and services in the aerospace, defense, industrial, and finance sectors.

Why Does TXT Worry Us?

1. Annual sales growth of 4% over the last two years lagged behind its industrials peers as its large revenue base made it difficult to generate incremental demand
2. Earnings growth underperformed the sector average over the last two years as its EPS grew by just 4.5% annually
3. Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 3.4 percentage points

Textron’s stock price of $98.25 implies a valuation ratio of 15.2x forward P/E. To fully understand why you should be careful with TXT, check out our full research report (it’s free).

3M (MMM)

Consensus Price Target: $178.20 (3.5% implied return)

Producers of the first asthma inhaler, 3M Company (NYSE: MMM) is a global conglomerate known for products in industries like healthcare, safety, electronics, and consumer goods.

Why Are We Out on MMM?

1. Absence of organic revenue growth over the past two years suggests it may have to lean into acquisitions to drive its expansion
2. Estimated sales growth of 3.7% for the next 12 months is soft and implies weaker demand
3. Falling earnings per share over the last five years has some investors worried as stock prices ultimately follow EPS over the long term

At $172.20 per share, 3M trades at 20.1x forward P/E. Dive into our free research report to see why there are better opportunities than MMM.

Stocks We Like More

The market’s up big this year - but there’s a catch. Just 4 stocks account for half the S&P 500’s entire gain. That kind of concentration makes investors nervous, and for good reason. While everyone piles into the same crowded names, smart investors are hunting quality where no one’s looking - and paying a fraction of the price. Check out the high-quality names we’ve flagged in our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.